Patents by Inventor Wolf-Ruediger Ulrich

Wolf-Ruediger Ulrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOPYRIDINE DERIVATIVES USEFUL AS INOS INHIBITORS
    Publication number: 20100317650
    Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: August 3, 2010
    Publication date: December 16, 2010
    Applicant: NYCOMED GmbH
    Inventors: Thomas FUCHSS, Andreas STRUB, Wolf-Rüdiger ULRICH, Christian HESSLINGER, Martin LEHNER, Raimund Külzer, Rainer BOER, Manfrid ELTZE
  • Imidazopyridine derivatives useful as iNOS inhibitors
    Patent number: 7790710
    Abstract: The compounds of formula (I) in which R1, R11 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: September 7, 2010
    Assignee: NYCOMED GmbH
    Inventors: Thomas Fuchss, Andreas Strub, Wolf-Rüdiger Ulrich, Christian Hesslinger, Martin Lehner, Raimund Külzer, Rainer Boer, Manfrid Eltze
  • IMIDAZOPYRIDINE-DERIVATIVES AS INDUCIBLE NO-SYNTHASE INHIBITORS
    Publication number: 20100216790
    Abstract: The compounds of formula (I) In which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: May 3, 2010
    Publication date: August 26, 2010
    Applicant: ALTANA PHARMA AG
    Inventor: Wolf-Ruediger ULRICH
  • Imidazopyridine-derivatives as inducible no-synthase inhibitors
    Patent number: 7709488
    Abstract: The compounds of formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: September 27, 2007
    Date of Patent: May 4, 2010
    Assignee: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Imidazopyridine-derivatives as inductible no-synthase inhibitors
    Publication number: 20090036482
    Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 26, 2008
    Publication date: February 5, 2009
    Applicant: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Imidazopyridine-derivatives as inductible no-synthase inhibitors
    Patent number: 7468377
    Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: December 23, 2008
    Assignee: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
    Publication number: 20080242681
    Abstract: Compounds of a certain formula 1 in which R1 and R2 have the meanings indicated in the description are novel kinase inhibitors. Formula (1), in which R1 is phenyl, phenyl substituted by R3 and/or R4, naphthalenyl, naphthalenyl substituted by and/or R6, aryl1, aryl1 substituted by R7 and/or R8, R9, R10 or R11, R2 is phenyl, phenyl substituted by R12 and/or R13, naphthalenyl, naphthalenyl substituted by R14 and/or R15, aryl2, aryl2 substituted by R16 and/or R17 or a radical selected from Formula (2).
    Type: Application
    Filed: January 19, 2005
    Publication date: October 2, 2008
    Applicant: Altana Pharma AG
    Inventors: Johannes Barsig, Monika Baudler, Daniela Bundschuh, Florian Gantner, Ulrich Graedler, Isabelle Heit, Thomas Martin, Michaela Schaefer, Imre Schlemminger, Josef Stadlwieser, Wolf-Ruediger Ulrich
  • Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors
    Patent number: 7390819
    Abstract: The compounds of formula I in which R1, R2, R3 and A have the meanings as given in the description are novel effective INOS inhibitors.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: June 24, 2008
    Assignee: Altana Pharma AG
    Inventors: Thomas Martin, Wolf-Ruediger Ulrich
  • Imidazopyridine-Derivatives As Inducible No-Synthase Inhibitors
    Publication number: 20080125460
    Abstract: The compounds of Formula (I) in which R1, R2, Het1 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 30, 2004
    Publication date: May 29, 2008
    Applicant: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Imidazopyridine-derivatives as inducible no-synthase inhibitors
    Publication number: 20080021039
    Abstract: The compounds of formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 27, 2007
    Publication date: January 24, 2008
    Inventor: Wolf-Ruediger Ulrich
  • Imidazopyridine-derivatives as inducible no-synthase inhibitors
    Patent number: 7279488
    Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: October 9, 2007
    Assignee: Nycomed GmbH
    Inventor: Wolf-Ruediger Ulrich
  • Use of bh4 for the treatment of respiratory diseases
    Publication number: 20070049599
    Abstract: The invention describes the use of Tetrahydrobiopterin (BH4) or derivatives thereof for the treatment of COPD. In a preferred embodiment, BH4 or derivates thereof are combined with arginine or derivatives thereof.
    Type: Application
    Filed: October 29, 2004
    Publication date: March 1, 2007
    Applicant: Altana Pharma AG
    Inventors: Christian Hesslinger, Wolf-Ruediger Ulrich, Christian Schudt
  • Imidazopyridine-derivatives as inductible no-synthase inhibitors
    Publication number: 20070043073
    Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 30, 2004
    Publication date: February 22, 2007
    Applicant: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Surfactant protein C esters
    Patent number: 7173009
    Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: February 6, 2007
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Ernst Sturm
  • Imidazopyridine-derivatives as inducible no-synthase inhibitors
    Publication number: 20060293302
    Abstract: The compounds of Formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.
    Type: Application
    Filed: September 30, 2004
    Publication date: December 28, 2006
    Applicant: Altana Pharma AG
    Inventor: Wolf-Ruediger Ulrich
  • Alkoxypyridine-derivatives
    Patent number: 7138399
    Abstract: The compounds of formula I in which R1 is 1–4C-alkoxy, A is 1–4C-alkylene, B represents 3H-imidazo[4,5-b]pyridin-2-yl, 3H-imidazo[4,5-b]pyridin-2-yl substituted by R2 and/or R3, 9H-purin-8-yl or 9H-purin-8-yl substituted by R4 and/or R5, are effective iNOS inhibitors.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: November 21, 2006
    Assignee: Altana Pharma AG
    Inventor: Wolf-Rüdiger Ulrich
  • Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors
    Publication number: 20060160839
    Abstract: The compounds of formula I in which R1, R2, R3 and A have the meanings as given in the description are novel effective INOS inhibitors.
    Type: Application
    Filed: February 24, 2004
    Publication date: July 20, 2006
    Applicant: Altana Pharma AG
    Inventors: Thomas Martin, Wolf-Ruediger Ulrich
  • Surfactant protein C esters
    Patent number: 7022671
    Abstract: Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: April 4, 2006
    Assignee: Altana Pharma AG
    Inventors: Wolf-Rüdiger Ulrich, Ernst Sturm
  • Tryptase inhibitors
    Patent number: 6962941
    Abstract: The compounds of formula I in which M, B1, B2, R1, R2, R6, R7, K1 and K2 have the meanings as indicated in the description are novel active tryptase inhibitors.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: November 8, 2005
    Assignee: Altana Pharma AG
    Inventors: Thomas Martin, Wolf-Rüdiger Ulrich
  • Diazocine derivatives and their use as tryptase inhibitors
    Patent number: 6924305
    Abstract: Compounds of the formula I, in which B1, B2, R1, R2, R6, R7, K1 and K2 are as defined in the description are novel effective tryp-tase inhibitors.
    Type: Grant
    Filed: January 26, 2002
    Date of Patent: August 2, 2005
    Assignee: Altana Pharma AG
    Inventor: Wolf-Rüdiger Ulrich